Clinical Research
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2007; 13(9): 1422-1426
Published online Mar 7, 2007. doi: 10.3748/wjg.v13.i9.1422
Figure 1
Figure 1 ERC/X-ray contrast of the bile duct system in a 57-year old patient with hilar cholangiocarcinoma (Bismuth IV).
Figure 2
Figure 2 Algorithm of treatment strategies.
Figure 3
Figure 3 Kaplan-Meier estimate for survival depending on Bismuth stage at the time of initial diagnosis in 76 (A) initial serum bilirubin levels (B), and endoscopic procedure (ERC vs ERC/PTBD) (C) in 76 non resected patients.
Figure 4
Figure 4 Mean survival depending on patients age in the non resected group (n = 76).